Cargando…

Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report

BACKGROUND: Angiosarcoma of the breast is very rare and can be divided into primary and secondary angiosarcoma. Radiation-induced angiosarcoma (RIAS) is classified as secondary angiosarcoma. Diagnosis of RIAS is difficult due to its rarity, and the interpretation of pathological imaging is complicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Yoko, Taniguchi, Kohei, Hatono, Minami, Kajiwara, Yukiko, Abe, Yuko, Kawada, Kengo, Tsukioki, Takahiro, Kochi, Mariko, Nishiyama, Keiko, Iwamoto, Takayuki, Ikeda, Hirokuni, Shien, Tadahiko, Taira, Naruto, Tabata, Masahiro, Yanai, Hiroyuki, Doihara, Hiroyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965539/ https://www.ncbi.nlm.nih.gov/pubmed/31950295 http://dx.doi.org/10.1186/s40792-020-0790-7

Ejemplares similares

Influences of preoperative metformin on immunological factors in early breast cancer
por: Tsukioki, Takahiro, et al.
Publicado: (2020)

Effect of local surgery on outcomes of stage IV breast cancer
por: Tsukioki, Takahiro, et al.
Publicado: (2020)

YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development
por: Fujihara, Miwa, et al.
Publicado: (2021)

A Radial Sclerosing Lesion Mimicking Breast Cancer on Mammography in a Young Woman
por: Furukawa, Masashi, et al.
Publicado: (2012)

The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells
por: Ikeda, Hirokuni, et al.
Publicado: (2010)

A Multicenter Study of Docetaxel at a Dose of 100 mg/m(2) in Japanese Patients with Advanced or Recurrent Breast Cancer
por: Hirata, Taizo, et al.
Publicado: (2020)

A Case of Carcinoma Showing Thymus-Like Differentiation with a Rapidly Lethal Course
por: Nogami, Tomohiro, et al.
Publicado: (2014)

Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer
por: Fujita, Takeo, et al.
Publicado: (2009)

Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers
por: Iwamoto, Takayuki, et al.
Publicado: (2017)

Fertility preservation in breast cancer patients
por: Shien, Tadahiko, et al.
Publicado: (2013)

Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case–control study in Japanese women
por: Mizoo, Taeko, et al.
Publicado: (2013)

Breast Cancer Metastasis to the Stomach That Was Diagnosed after Endoscopic Submucosal Dissection
por: Kita, Masahide, et al.
Publicado: (2016)

DNA methylation status of REIC/Dkk-3 gene in human malignancies
por: Hayashi, Tatsuro, et al.
Publicado: (2012)

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer
por: Sato, Hiroki, et al.
Publicado: (2018)

Propranolol and Weekly Paclitaxel in the Treatment of Metastatic Heart Angiosarcoma
por: Fiste, Oraianthi, et al.
Publicado: (2020)

Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma
por: Roy, Amit, et al.
Publicado: (2021)

Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma
por: Apice, Gaetano, et al.
Publicado: (2016)

Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy
por: Kikawa, Yuichiro, et al.
Publicado: (2022)

Doxorubicin, paclitaxel, and cisplatin based chemotherapy for the treatment of angiosarcoma: Two case reports
por: Lewcun, Joseph A., et al.
Publicado: (2020)

Recurring Themes
por: Imperiale, Michael J.
Publicado: (2020)

Recurring Grippe
por: Love, I. N.
Publicado: (1894)

Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient(®) in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
por: Pink, Daniel, et al.
Publicado: (2021)

Dramatic Recovery from Cardiovascular Collapse: Paclitaxel as an Urgent Treatment for Primary Cardiac Angiosarcoma
por: Suzuki, Toshio, et al.
Publicado: (2020)

Radiation-induced angiosarcoma of the brain
por: Hoshiai, Sodai, et al.
Publicado: (2015)

Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study
por: Shien, Tadahiko, et al.
Publicado: (2017)

Recurring Cervical Chondroma
Publicado: (1928)

Paclitaxel as Neoadjuvant Therapy for High Grade Angiosarcoma of the Spleen: a Brief Report and Literature Review
por: Vakkalanka, Bhanu, et al.
Publicado: (2010)

Case report: Gastric cancer‐associated membranous nephropathy that recurred after complete remission and formation of peritoneal dissemination
por: Kajiwara, Nobuyuki, et al.
Publicado: (2019)

Long-Term Survival due to Chemotherapy including Paclitaxel in a Patient with Metastatic Primary Splenic Angiosarcoma
por: Takehara, Masanori, et al.
Publicado: (2021)

Recurring Jaundice in Successive Pregnancies
Publicado: (1914)

Recurring Facial Erythema in an Infant
por: Hassan, Sam, et al.
Publicado: (2016)

Recurring Torsion of the Spermatic Cord
por: Dowden, J. W.
Publicado: (1905)

Recurring Luxation of the Lower Jaw
Publicado: (1891)

Pilomatrixoma Recurring as Giant Form
por: Tavares, Ana Teresa, et al.
Publicado: (2022)

Pediatric ependymomas: destined to recur?
por: Ritzmann, Timothy A, et al.
Publicado: (2021)

Impact of breast surgery in de novo stage IV breast cancer
por: Shien, Tadahiko
Publicado: (2019)

Angiosarcoma
por: Jaitley, Shweta
Publicado: (2012)

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer
por: Miyoshi, Yuichiro, et al.
Publicado: (2019)

A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)
por: Oashi, Kohei, et al.
Publicado: (2020)

Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence
por: Miyoshi, Yuichiro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0ibfvb7savekm1lioijg8qqi5s